Loading...
The Pharmacologic Treatment of Stuttering and Its Neuropharmacologic Basis
Stuttering is a DSM V psychiatric condition for which there are no FDA-approved medications for treatment. A growing body of evidence suggests that dopamine antagonist medications are effective in reducing the severity of stuttering symptoms. Stuttering shares many similarities to Tourette’s Syndrom...
Na minha lista:
| Udgivet i: | Front Neurosci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7118465/ https://ncbi.nlm.nih.gov/pubmed/32292321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2020.00158 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|